|
|
||||||||
From Central Nebraska Neurology, Hastings, NE.
Address correspondence and reprint requests to Dr. Lorraine L. Edwards, Central Nebraska Neurology, 2727 W. 2nd Street, Suite 340, Hastings, NE 68901; e-mail: centralnn{at}alltel.net
Controversy continues regarding the safety and efficacy of tissue plasminogen activator (tPA) for stroke outside major centers. We reviewed charts from 1998 to 2004 of 493 patients admitted with TIA or stroke to our small rural hospital. There was a 4% tPA treatment rate with no symptomatic intracranial hemorrhage and zero mortality. IV tPA can be safe and effective in the treatment of acute stroke despite the size of the institution.
Commentary, see page 247
Disclosure: The author reports no conflicts of interest.
Received June 5, 2006. Accepted in final form November 6, 2006.
Related Article
Neurology 2007 68: 247.
This article has been cited by other articles:
![]() |
J. Joubert, L. F. Prentice, T. Moulin, S.-T. Liaw, L. B. Joubert, P.-M. Preux, D. Ware, E. Medeiros de Bustos, and A. McLean Stroke in Rural Areas and Small Communities Stroke, June 1, 2008; 39(6): 1920 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M O McCarron, M Armstrong, and P McCarron Potential for quality improvement of acute stroke management in a district general hospital Emerg. Med. J., May 1, 2008; 25(5): 270 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Lyden January 23 Highlight and Commentary: Using tPA for acute stroke in a rural setting Neurology, January 23, 2007; 68(4): 247 - 247. [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |